Sebacia Announces $36 Million Equity and Debt Financing to Advance Breakthrough In-Office Procedure for Acne
Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund. New investors accounted for approximately 60 percent of the round and include Salem Partners and other undisclosed investors. Additionally, Sebacia closed a $16 million debt facility with Hercules Capital.
Printed from https://innovationblog.partners.org/sebacia-announces-36-million-equity-debt-financing-advance-breakthrough-office-procedure-acne · Published 07 Nov 2018
© Mass General Brigham Incorporated. All rights reserved.